Bio-Hpf Canada (2015-05-25)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Natural health products
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 403082B | - Recalling Firm
- NHP Consulting
- 1731 8th Ave NW
- Calgary
- T2N 1C5
- Alberta
- CANADA
- Marketing Authorization Holder
- Biotics Research Corporation
- 6801 Biotics Research Dr
- Rosenberg
- 77471
- Texas
- UNITED STATES
| Bio-Hpf Canada | Capsule | NPN 80048395 | 5,6-Dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium chloride 40.0 mg |
Recalled Products
Bio-Hpf Canada
Lead exceeds the acceptable limit of 10 mcg/day as per quality of Natural Health Products Guide.